TOPIC:

Pfizer

Watch breaking news videos and read news updates about Pfizer on FOXBusiness.com.

LATEST VIDEOS

What Big Pharma Gains From Health Reform

10/19/2009|FOX Business

What Big Pharma Gains From Health ReformLeerink Swann's John Sullivan on health reform's impact on the pharmaceutical industry.

Fixing Ireland's Economy

10/16/2009|Opening Bell

Fixing Ireland's EconomyIreland's Minister for Foreign Affairs Micheal Martin on his plans for Ireland's economy.

Stimulus: Pass or Fail?

10/12/2009|Web Exclusive

Stimulus: Pass or Fail?We break down if the government spending plan has hit the mark or missed its target.

Midday Market Update 10-12-09

10/12/2009|FOX Business

Midday Market Update 10-12-09Pfizer faces a setback, halting enrollments in a clinical trial. Meanwhile, Citi faces a fine.

Wall Street Wants More Money

10/06/2009|Happy Hour on FOX Business

Wall Street Wants More MoneyCody sounds off on why one-third of Wall Street is hungry for more cash.

Gov't too Price-Conscious on Health Care?

08/27/2009|FOX Business

Gov't too Price-Conscious on Health Care?FBN's Liz MacDonald on how the government views health-care costs.

Muriel Siebert on Markets, Kennedy

08/26/2009|FOX Business

Muriel Siebert on Markets, KennedyMuriel Siebert & Co. CEO Muriel Siebert on the state of the markets.

P&G Sheds Rx Business

08/24/2009|Money for Breakfast

P&G Sheds Rx BusinessThe Cincinnati Enquirer reporter David Holthaus and Leerink Swann Managing Director Adam Berger on P&G's deal to sell its prescription drug business.

The State of the 401(k)

08/18/2009|Web Exclusive

The State of the 401(k)As the market continues to fight for a rebound where does your retirement plan stand? Check out the full hour of FOXBusiness.com LIVE today.

Health Insurers the Scapegoat?

08/12/2009|Happy Hour on FOX Business

Health Insurers the Scapegoat?Acorda Capital Management Managing Director Scott Gottlieb on reports that health insurers helped write health-care legislation even though President Obama blamed them for many of the problems in health care.

LATEST STORIES

Vivus Reports Postive Study Results For ED Drug

By By Val Brickates Kennedy| MarketWatch Pulse| Markets

can effectively compete in the oral ED therapy market," Wilson added. Other PDE5 inhibitors for ED include Eli Lilly & Co.'s Cialis, Pfizer Inc.'s Viagra, and GlaxoSmithKline plc's Levitra. Copyright © 2009 MarketWatch, Inc.

Story|11/18/2009

Bausch & Lomb Names Former Schering CEO to Board

FOXBusiness| Markets

2003 until the company was acquired by Merck (MRK) in October. Hassan previously worked for Pharmacia, which was sold to Pfizer (PFE) in 2003. On Thursday, Bausch & Lomb Chairman and CEO Gerald Ostrov said, "We will especially value Fred's insights

Story|11/12/2009

Tuesday Stories: Life On Severance; New York “On The Brink;” Digital Distractions « The Brian

The Brian Sullivan Blog

entitlement spending Dodd unveiling financial reform plan Counting the jobs created by stimulus Taxing Private Ryan Bullish on Walmart Pfizer slashing R&D spending, closing facilities Krugman: How much was Reagan's fault? Should we tax soda and sugar-rich fruit

Blog|11/10/2009

Pfizer to Reduce Research Operations

By Kathryn Glass| FOXBusiness| Markets

Wyeth last month, pharmaceutical colossus Pfizer (PFE) announced plans to close six of its research ..... will address unmet medical need and bring Pfizer ’s scientific and competitive advantage ..... improve productivity while cutting costs. Pfizer said the changes would reduce square footage

Story|11/09/2009

Pfizer To Shutter Six Out Of 20 R&D Sites

By Wallace Witkowski| MarketWatch Pulse| Markets

Witkowski MarketWatch Pulse SAN FRANCISCO -- Pfizer Inc. said Monday it will "significantly ..... sites and shut down six out its 20 sites. Pfizer said it will shut down its R&D operations ..... and St. Louis to other locations. Pfizer said the moves will result in staff reductions

Story|11/09/2009

Stocks In Focus For Friday

By MarketWatch| MarketWatch| Markets

would earn 46 cents a share on $2.9 billion in revenue. Pfizer Inc. (PFE) said its board has approved the measure of giving ..... on executive compensation. The first vote will take place at Pfizer 's 2010 annual shareholders meeting and will occur again every

Story|10/29/2009

Pfizer To Allow Shareholder Vote On Executive Pay

By Wallace Witkowski| MarketWatch Pulse| Markets

Wallace Witkowski MarketWatch Pulse SAN FRANCISCO -- Pfizer Inc. said late Thursday that its board has approved the measure ..... on executive compensation. The first vote will take place at Pfizer 's 2010 annual shareholders meeting and occur every other year

Story|10/29/2009

Pfizer Employs Unique Strategy of 'More Is Less'

By Dunstan Prial| FOXBusiness| Markets

Dunstan Prial FOXBusiness Pfizer Chief Executive Officer Jeff Kindler seems to want it both ways. He wants Pfizer (PFE) to remain the largest drug maker ..... pushing his company in both directions. Pfizer ’s recent third-quarter results suggest

Story|10/28/2009

Drug Stocks Decline; Pfizer Rises On Earnings

By Val Brickates Kennedy| MarketWatch Pulse| Markets

Drug stocks declined in early trading Tuesday as shares of Pfizer Inc. rose after it issued a better-than-expected earnings ..... Biotechnology Index was down 1.4% at 917.34. Shares of Pfizer were up almost 2% at $18.29. Copyright © 2009 MarketWatch

Story|10/20/2009

Pfizer Profit Rises in 3Q, Tops Street

Reuters| Markets

Reuters NEW YORK-- Pfizer Inc (PFE) reported higher third-quarter ..... share, a year ago. Excluding items, Pfizer earned 51 cents per share. Analysts ..... analysts' estimates of $11.41 billion. Pfizer 's bought Wyeth to help soften the 2011

Story|10/20/2009